Patents Issued in February 5, 2002
  • Patent number: 6344299
    Abstract: Provided is a photopolymerization initiator which has a high sensitivity and is inexpensive and which does not cause precipitation of crystals when kept in cold storage after diluted and dissolved in an organic solvent.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: February 5, 2002
    Assignee: Chisso Corporation
    Inventors: Hiroyuki Sato, Takanori Fukumura, Fumitaka Ooizumi, Takashi Kato
  • Patent number: 6344300
    Abstract: A color filter comprising a transparent substrate, a light-shielding layer patterned on said transparent substrate, and colored pixels of plural colors patterned on a portion of said substrate where said light-shielding layer is not formed, wherein said colored pixels of at least one color are formed from a photosensitive coloring composition comprising: (A) a pigment; (B) a copolymer of (meth)acrylic acid, as one monomer, and at least one other monomer; (C) a photopolymerizable monomer; (D) a photopolymerizable initiator; and (F) a solvent; and an acid value of a nonvolatile component of said photosensitive coloring composition is 25 through 60 mg KOH/g; and after forming the colored pixels from a photosensitive coloring composition, the light-shielding layer attains reflectance at 380 through 780 nm of 95% or more of reflectance thereof before coating the photosensitive coloring composition; and the transparent portion of the substrate attains transmittance at 380 through 780 nm of 99.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: February 5, 2002
    Assignee: Sumitomo Chemical Co., Ltd.
    Inventors: Koji Baba, Shigeo Hozumi
  • Patent number: 6344301
    Abstract: A method of forming a colored film includes a step of forming a substrate for electrodeposition by laminating at least a transparent conductive film and a thin transparent photosemiconductor film having a photovoltaic function in this order on the surface of a support having an electronic circuit materialthereon, and a step of irradiating with a light at least a thin photosemiconductor film of the substrate for electrodeposition while bringing the same into contact with an aqueous electrolyte containing an electrodeposition material containing a colorant, thereby selectively generating a photoelectromotive force to an irradiated area of the thin photosemiconductor film and electrochemically depositing the electrodeposition material to form a colored electrodeposition film; an electronic driving device containing the colored film and a liquid crystal display device having the electronic driving device, the method capable of forming the colored film of high quality and excellent surface smoothness being formed
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: February 5, 2002
    Assignee: Fuji Xerox Co., Ltd.
    Inventors: Eiichi Akutsu, Shigemi Ohtsu, Takao Tomono, Keishi Shimizu
  • Patent number: 6344302
    Abstract: A developer for developing an electrostatic latent image comprising: toner particles comprising a colorant and a binder resin, said toner particles having a volume-average particle size of 5 to 10 &mgr;m; a first exterior additive comprising hydrophobic titanium oxide powder or hydrophobic aluminum oxide powder; and a second exterior additive comprising a silica powder; said developer satisfying following relationships: S1>S2 400<{square root over ((S12+L +S22+L ))}≦1300. wherein S1 (m2) denotes total specific surface area of the first additive per 1 kg of the toner and S2 (m2) denotes that of the second additive.
    Type: Grant
    Filed: February 13, 1996
    Date of Patent: February 5, 2002
    Assignee: Minolta Co., Ltd.
    Inventors: Katsunori Kurose, Masayuki Hagi, Tetsuo Sano, Kenichi Kido, Takeshi Arai
  • Patent number: 6344303
    Abstract: A preparation method of an image forming material comprising a support having thereon at least an image forming layer is desclosed, comprising subjecting one side of the support to a treatment to modify the surface of the support and coating an image forming layer on the surface-modified support, wherein the image forming layer contains a resin containing a polar group and an compound containing an isocyanate group and the modified surface of the support exhibiting a surface energy of 45 to 60 dyne/cm, and wherein the image forming material is imagewise exposed to a high density energy light, thereby making an exposed area of the image forming layer removable and removing the removable image forming layer to form an image.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: February 5, 2002
    Assignee: Konica Corporation
    Inventor: Hideki Takahashi
  • Patent number: 6344304
    Abstract: A radiation sensitive composition comprising a copolymer having a structural unit of (me)acrylonitrile and a structural unit generating an alkali soluble group and a substance generating an acid by application of radiation.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: February 5, 2002
    Assignee: Fujitsu Limited
    Inventors: Satoshi Takechi, Makoto Takahashi, Yuko Kaimoto
  • Patent number: 6344305
    Abstract: A high-performance radiation sensitive silicon-containing negative-tone resist is provided along with a method of using the silicon-containing resist in multilayer, including bilayer, imaging for manufacturing semiconductor devices. The negative-tone silicon-containing resist is based on an acid catalyzed high-contrast crosslinking of aqueous base soluble silicon-containing phenolic polymers through reaction of a carbocation of the crosslinking agent with the hydroxyl site of the phenolic group in the silicon-containing polymers. A chemically amplified silicon-containing negative-tone resist composition comprising said silicon-containing polymer resin; at least one crosslinking agent; one acid generator; and a solvent is provided. The silicon-containing resist composition has high silicon content and provide excellent resolution and a means of patterning high aspect ratio resist patterns.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: February 5, 2002
    Assignee: International Business Machines Corporation
    Inventors: Qinghuang Lin, Ahmad D. Katnani, Douglas Charles LaTulipe, Jr., David E. Seeger, William Ross Brunsvold, Ali Afzali-Ardakani
  • Patent number: 6344306
    Abstract: This invention provides a directly imageable planographic printing plate precursor with excellent image reproducibility without requiring any complicated process after irradiation with a laser beam. To solve the above problem, this invention is constituted as describe below. A directly imageable waterless planographic printing plate precursor, in which at least an ink acceptable layer and a silcone rubber layer are laminated in this order on a substrate, wherein when the printing plate precursor is measured by TG-GC/MS in a hellium current at a heating rate of 10° C./min, a decomposition product is generated in a temperature range of 100° C. to 200° C. by 0.001 g/m2 to 1 g/m2 per plate area.
    Type: Grant
    Filed: March 9, 2000
    Date of Patent: February 5, 2002
    Assignee: Toray Industries, Inc.
    Inventors: Kunitaka Fujiyoshi, Kazuki Goto, Kimikazu Nagase, Gentaro Ohbayashi
  • Patent number: 6344307
    Abstract: A photosensitive resin composition characterized by comprising (A) a resin having at least one aprotic onium salt represented by the general formula: —COO−·W+  (1) and/or the general formula: (in each of the above general formulas, W+ represents wherein, Z represents a nitrogen atom or phosphorus atom; Y represents a sulfur atom; R1, R2, R3 and R4 each represents an organic group having 1 to 30 carbon atoms), (B) a compound having two or more vinylether groups in a molecule and (C) a compound which generates an acid upon irradiation with actinic energy rays.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: February 5, 2002
    Assignee: Kansai Paint Co., Ltd.
    Inventors: Daisuke Kojima, Osamu Isozaki, Hideo Kogure, Genji Imai
  • Patent number: 6344308
    Abstract: A flexible circuit board comprises a polyimide insulating layer 5 with land access holes 3 and a conductor circuit layer 4 provided thereon, and is produced by coating one surface of a conductor circuit metal foil 1 side with a polyimide precursor varnish, which is dried to give a polyimide precursor layer 2, where the polyimide precursor layer 2 is provided with land access holes 3 by a photolithography process; the conductor circuit metal foil 1 is patterned by the subtractive process to form conductor circuit layer 4; and the polyimide precursor layer 4 is then imidated to form polyimide insulating layer 5.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: February 5, 2002
    Assignee: Sony Chemicals Corp.
    Inventors: Hideyuki Kurita, Satoshi Takahashi, Akira Tsutsumi
  • Patent number: 6344309
    Abstract: A metal pattern is prepared by applying a polysilane composition comprising a polysilane, a carbon functional silane, and a solvent onto a substrate to form a patterned coating of the polysilane composition, attaching catalytic metal nuclei to the patterned coating, and immersing the substrate in an electroless plating bath for thereby chemically depositing a metal film on the patterned coating.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: February 5, 2002
    Assignee: Shin-Etsu Chemical Co., Ltd.
    Inventors: Motoo Fukushima, Kunio Ito, Shigeru Mori
  • Patent number: 6344310
    Abstract: The invention relates to a photographic element consisting essentially of a transparent biaxially oriented polymer sheet, at least one emulsion adhering layer, and at least one light sensitive silver halide grain containing emulsion layer adhered to said emulsion adhering layer, wherein said polymer sheet is less than 76 micrometers.
    Type: Grant
    Filed: November 20, 1998
    Date of Patent: February 5, 2002
    Assignee: Eastman Kodak Company
    Inventors: Robert P. Bourdelais, Peter T. Aylward, Thaddeus S. Gula, Alphonse D. Camp
  • Patent number: 6344311
    Abstract: A photosensitive element comprising a silver halide emulsion having silver halide grains containing an organic hole-trapping dopant.
    Type: Grant
    Filed: September 21, 2000
    Date of Patent: February 5, 2002
    Assignee: Agfa-Gevaert
    Inventors: René De Keyzer, Mona Treguer, Jacqueline Belloni, Remita Hynd
  • Patent number: 6344312
    Abstract: The present application discloses a heat developable photosensitive material having on a support a non-photosensitive silver salt, a photosensitive silver halide, and a binder, which has a layer formed by coating a coating composition comprising an emulsion containing both of the photosensitive silver halide and a low molecular weight gelatin having a molecular weight of 500 to 60,000. The heat developable photosensitive material provides excellent photographic properties such as low fog, high Dmax, high sensitivity, and the like, as well as good coating surface.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: February 5, 2002
    Assignee: Fuji Photo Film Co., Ltd.
    Inventor: Takahiro Goto
  • Patent number: 6344313
    Abstract: An object of the present invention is to provide a heat-developable photosensitive material of improved fluctuation of photographic performance (sensitivity, Dmin) arisen from fluctuation of development temperature condition (temperature, time) and storage time after heat development.
    Type: Grant
    Filed: March 30, 2000
    Date of Patent: February 5, 2002
    Assignee: Fuji Photo Film Co., Ltd.
    Inventors: Takahiro Goto, Toshihide Ezoe, Hiroyuki Suzuki, Minoru Sakai, Hideki Maeta, Nobuaki Inoue, Masaru Takasaki
  • Patent number: 6344314
    Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively: 76-556 543-864 867-2811 2728-3808 3326-3575 3842-4079 4198-5611 5516-8091 The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: February 5, 2002
    Assignee: Institut Pasteur
    Inventors: Stewart Cole, Rolf E. Streeck
  • Patent number: 6344315
    Abstract: Methods and compositions for staining based upon nucleic acid sequence that employ nucleic acid probes are provided. Said methods produce staining patterns that can be tailored for specific cytogenetic analyses. Said probes are appropriate for in situ hybridization and stain both interphase and metaphase chromosomal material with reliable signals. The nucleic acid probes are typically of a complexity greater than 50 kb, the complexity depending upon the cytogenetic application. Methods and reagents are provided for the detection of genetic rearrangements. Probes and test kits are provided for use in detecting genetic rearrangements, particularly for use in tumor cytogenetics, in the detection of disease related loci, specifically cancer, such as chronic myelogenous leukemia (CML), retinoblastoma, ovarian and uterine cancers, and for biological dosimetry.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 5, 2002
    Assignee: The Regents of The University of California
    Inventors: Joe W. Gray, Daniel Pinkel, Olli-Pekka Kallioniemi, Anne Kallioniemi, Masaru Sakamoto
  • Patent number: 6344316
    Abstract: The present invention provides a simplified method for identifying differences in nucleic acid abundances (e.g., expression levels) between two or more samples. The methods involve providing an array containing a large number (e.g. greater than 1,000) of arbitrarily selected different oligonucleotide probes where the sequence and location of each different probe is known. Nucleic acid samples (e.g. mRNA) from two or more samples are hybridized to the probe arrays and the pattern of hybridization is detected. Differences in the hybridization patterns between the samples indicates differences in expression of various genes between those samples. This invention also provides a method of end-labeling a nucleic acid. In one embodiment, the method involves providing a nucleic acid, providing a labeled oligonucleotide and then enzymatically ligating the oligonucleotide to the nucleic acid. Thus, for example, where the nucleic acid is an RNA, a labeled oligoribonucleotide can be ligated using an RNA ligase.
    Type: Grant
    Filed: June 25, 1997
    Date of Patent: February 5, 2002
    Assignee: Affymetrix, Inc.
    Inventors: David J. Lockhart, Mark Chee, Kevin Gunderson, Lai Chaoqiang, Lisa Wodicka, Maureen T. Cronin, Danny Lee, Huu M. Tran, Hajime Matsuzaki
  • Patent number: 6344317
    Abstract: This invention provides sensitive nucleic acid hybridization assay methods for the detection of target human nucleic acids in a biological sample, such as acellular fluids. The methods are particularly useful in early diagnosis of chronic illnesses.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: February 5, 2002
    Assignee: Chronix Biomedical, Inc.
    Inventor: Howard B. Urnovitz
  • Patent number: 6344318
    Abstract: The present invention includes methods for the identification and production of improved nucleic acid ligands based on the SELEX process. Also included are nucleic acid ligands to the HIV-RT protein identified according to the methods described therein.
    Type: Grant
    Filed: October 2, 1998
    Date of Patent: February 5, 2002
    Assignee: Gilead Sciences, Inc.
    Inventors: Larry Gold, Craig Tuerk
  • Patent number: 6344319
    Abstract: The invention concerns a method for detecting or locating one or several genes of one or several specific A DNA sequence or one or several molecules reacting with DNA on a B DNA characterised in that it consists in: (a) fixing and combing a certain amount of said B DNA on a combing surface; (b) reacting the product of the B combing with one or several probes, linked with the gene(s) or specific A DNA sequences, or with the molecules capable of reacting with DNA; (c) extracting information corresponding to at least one of the following categories: (1) the position of the probes, (2) the distance between the probes, (3) the size of the probes (the total sum of sizes for quantifying the number of hybridised probes) for determining therefrom the presence, the location and/or the amount of genes or specific A DNA sequences. This method can be used in particular for the diagnosis of genetic diseases.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: February 5, 2002
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique
    Inventors: Aaron Bensimon, David Bensimon, Xavier Michalet
  • Patent number: 6344320
    Abstract: The invention is directed to methods for the non-radioactive labeling, detection, quantitation and isolation of nascent proteins translated in a cellular or cell-free translation system. tRNA molecules are misaminoacylated with non-radioactive markers which may be non-native amino acids, amino acid analogs or derivatives, or substances recognized by the protein synthesizing machinery. Markers may comprise cleavable moieties, detectable labels, reporter properties wherein markers incorporated into protein can be distinguished from unincorporated markers, or coupling agents which facilitate the detection and isolation of nascent protein from other components of the translation system. The invention also comprises proteins prepared using misaminoacylated tRNAs which can be utilized in pharmaceutical compositions for the treatment of diseases and disorders in humans and other maninials, and kits which may be used for the detection of diseases and disorders.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: February 5, 2002
    Assignee: The Trustees of Boston University
    Inventors: Kenneth J. Rothschild, Sanjay M. Sonar, Jerzy Olejnik
  • Patent number: 6344321
    Abstract: The invention provides nucleic acid ligands to hepatocyte growth factor/scatter factor (HGF) and its receptor c-met. The nucleic acid ligands of the instant invention are isolated using the SELEX method. SELEX is an acronym for Systematic Evolution of Ligands by EXponential enrichment. The nucleic acid ligands of the invention are useful as diagnostic and therapeutic agents for diseases in which elevated HGF and c-met activity are causative factors.
    Type: Grant
    Filed: July 29, 1999
    Date of Patent: February 5, 2002
    Assignee: Gilead Sciences, Inc.
    Inventors: Ross Rabin, Michael Lochrie, Nebojsa Janjic, Larry Gold
  • Patent number: 6344322
    Abstract: The accumulation of homoplasmic somatic mutations has been observed in the mitochondrial DNA of certain tumor cells. The presence or recurrence of a tumor can be detected by determining the presence of single basepair mutations in the mitochondrial genome from a cell sample of a patient.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: February 5, 2002
    Assignee: The Johns Hopkins University
    Inventors: Kornelia Polyak, Bert Vogelstein, Kenneth W. Kinzler
  • Patent number: 6344323
    Abstract: The invention features antisense oligonucleotide molecules that specifically bind polynucleotides encoding COX-2. The present invention provides antisense oligonucleotides capable of inhibiting COX-2 expression, and methods of use thereof to reduce activity of COX-2 in tissues in order to treat diseases such as, for example, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, chronic liver disease, ulcerative colitis, cell proliferative disorders, and inflammation associated with Alzheimer's Disease and stroke.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: February 5, 2002
    Assignee: Vitagenix, Inc.
    Inventor: Wilfried Seifert
  • Patent number: 6344324
    Abstract: The present invention features a novel cellular injury reporter system in which a chimeric gene containing the GADD153 promoter linked to the coding region of an enhanced green fluorescent protein (EGFP) gene was stably integrated into the genome of carcinoma cells. Activation of the GADD153 promoter was quantified using flow cytometric measurement of EGFP expression following drug exposure. This reporter system is suitable for high. throughput in vitro and in vivo screening for agents capable of producing cytotoxicity via a wide variety of different mechanisms, and can be utilized to investigate the relative potency of structurally related DNA adducts.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: February 5, 2002
    Assignee: Research Development Foundation
    Inventors: Stephen B. Howell, Xinjian Lin, Dennis P. Gately
  • Patent number: 6344325
    Abstract: The invention relates to a microfabricated device and methods of using the device for analyzing and sorting individual polynucleotides, e.g., by size according to an optical signal measured within a detection region of the device. An optical signal such as fluorescence from a reporter molecule associated with the polynucleotide molecules can be used to determine polynucleotide size or to direct selected polynucleotides into one or more selected branch channels of the device.
    Type: Grant
    Filed: February 8, 2000
    Date of Patent: February 5, 2002
    Assignee: California Institute of Technology
    Inventors: Stephen Quake, Wayne D. Volkmuth
  • Patent number: 6344326
    Abstract: Integrated microfluidic devices comprising at least an enrichment channel (10) and a main electrophoretic flowpath (12) are provided. In the subject integrated devices, the enrichment channel and the main electrophoretic flowpath are positioned so that waste fluid flows away from said main electrophoretic flowpath through a discharge outlet (6). The subject devices find use in a variety of electrophoretic applications, including clinical assays, high throughput screening for genomics and pharmaceutical applications, point-or-care in vitro diagnostics, molecular genetic analysis and nucleic acid diagnostics, cell separations, and bioresearch generally.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: February 5, 2002
    Assignee: Aclara Bio Sciences, Inc.
    Inventors: Robert J. Nelson, Herbert H. Hooper, Alan K. Hauser, Sharat Singh, Stephen J. Williams, Alexander P. Sassi
  • Patent number: 6344327
    Abstract: The present invention relates to a system for identifying, isolating and utilizing promoter elements useful for expression of nucleotide sequences and the proteins encoded thereby in a thermophile. In one embodiment, a recombinant DNA molecule is provided, and comprises a reporter sequence, a putative thermophile promoter, a selectable marker sequence, and a 3′ and a 5′ DNA targeting sequence that are together capable of causing integration of at least a portion of said DNA molecule into the genome of a thermophile. Further, within the recombinant DNA, the reporter sequence is under the transcriptional control of a promoter which functions in a thermophile to form a promoter/reporter cassette, the promote/reporter cassette is flanked by said 3′ and said 5′ DNA targeting sequences, and the promoter/reporter cassette is positioned in the opposite orientation of the DNA targeting sequences.
    Type: Grant
    Filed: April 12, 2000
    Date of Patent: February 5, 2002
    Assignee: Thermogen, Inc.
    Inventors: Mikhail Peredultchuk, Veronica Vonstein, David Demirjian
  • Patent number: 6344328
    Abstract: Disclosed is a process for identifying clones having a specified enzyme activity by screening for the specified enzyme activity in a library of clones prepared by (i) selectively isolating target DNA from DNA derived from at least one microorganism, by use of at least one probe DNA comprising at least a portion of a DNA sequence encoding an enzyme having the specified enzyme activity; and (ii) transforming a host with isolated target DNA to produce a library of clones which are screened for the specified enzyme activity.
    Type: Grant
    Filed: April 24, 2000
    Date of Patent: February 5, 2002
    Assignee: Diversa Corporation
    Inventor: Jay M. Short
  • Patent number: 6344329
    Abstract: Disclosed are compositions and a method for of amplifying nucleic acid sequences useful for detecting the presence of molecules of interest. The method is useful for detecting specific nucleic acids in a sample with high specificity and sensitivity. The method also has an inherently low level of background signal. A preferred form of the method consists of a DNA ligation operation, an amplification operation, and a detection operation. The DNA ligation operation circularizes a specially designed nucleic acid probe molecule. This operation is dependent on hybridization of the probe to a target sequence and forms circular probe molecules in proportion to the amount of target sequence present in a sample. The amplification operation is rolling circle replication of the circularized probe. A single round of amplification using rolling circle replication results in a large amplification of the circularized probe sequences.
    Type: Grant
    Filed: August 23, 2000
    Date of Patent: February 5, 2002
    Assignee: Yale University
    Inventor: Paul M. Lizardi
  • Patent number: 6344330
    Abstract: The present invention is directed to novel methods for identifying small molecule ligands that are capable of binding with high affinity to a biological target molecule of interest. High affinity binding ligands identified by the described methods find use, for example, as small molecule lead compounds that may they themselves be, or may give rise to, novel therapeutic drugs. More specifically, the subject invention is directed to methods for identifying a ligand that binds to a target biological molecule of interest, wherein a population of small organic compounds are selected and then “pre-screened” to identify those that are capable of binding to the molecular target.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: February 5, 2002
    Assignee: The Regents of the University of California
    Inventors: Jonathan A. Ellman, Ingrid Choong
  • Patent number: 6344331
    Abstract: A biphase immunoassay method is provided in which a water immiscible liquid is qualitatively or quantitatively measured by mixing a sample of the water immiscible liquid with an aqueous solution containing a specific binding partner of the analyte. Binding occurs at or across the interface between the respective liquids and the degree of association of the analyte with its binding partner is dependent upon the concentration ratio rather than absolute quantities. The degree of association may be determined and used to determine the presence and/or concentration of analyte in the sample.
    Type: Grant
    Filed: October 23, 1998
    Date of Patent: February 5, 2002
    Assignee: Molecular Light Technology Research Limited
    Inventors: Raymond Lathan Ball, Jeremy Paul Aston, Jennifer Cryer, Ian Weeks
  • Patent number: 6344332
    Abstract: A method for the rapid detection of actively respiring microorganisms comprises the steps of detecting the presence of microorganisms utilizing microbial enzymatic conversion of tetrazolium salts to formazan products, detecting the presence of formazan product.
    Type: Grant
    Filed: September 4, 1998
    Date of Patent: February 5, 2002
    Assignee: Thaco Research, Ltd.
    Inventor: James Thacker
  • Patent number: 6344333
    Abstract: The present invention relates to an apparatus to perform reagent-free assays, which apparatus utilizes an all solid probe having an enzyme label that acts on a substrate by obtaining electrons directly from the electrode by bioelectrocatalysis.
    Type: Grant
    Filed: September 8, 1998
    Date of Patent: February 5, 2002
    Assignee: Synectig Corporation
    Inventor: Andrei L. Gindilis
  • Patent number: 6344334
    Abstract: Method for identifying a drug lead compound that inhibits binding of target bioogical molecules (TBM) by contacting TBM with members of a library of candidate cross-linked target binding fragments (CXBF), each CXBF having at least two candidate target bindig fragments (CTBF), which are inhibitors of binding, linked to a cross-linker, and selecting CXBF that inhibit the binding of the TBM to a greater extent than either of the individual CTBF linked to said cross-linker, wherein the library of CXBF is produced by: (a) screening a population of CTBF capable of being chemically cross-linked by a cross-linker to identify a subpopulation of the CTBF that inhibit binding of the TBM; and (b) chemically cross-linking members of the subpopulation of CTBF or structurally related analogs thereof with a cross-linker to provide a library of CXBF, wherein at least one linking group comprises an oxime ether linking group.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: February 5, 2002
    Assignee: The Regents of the University of California
    Inventors: Jonathan A. Ellman, Ingrid Choong
  • Patent number: 6344335
    Abstract: A liposome or microsphere containing guaiac or other reagent is used in an immunoassay to detect an antigen or antibody. The guaiac or other reagent reacts with hemoglobin or other blood constituent to produce color indicating a positive result.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: February 5, 2002
    Inventors: Francisco A. Tausk, Howard N. Robinson
  • Patent number: 6344336
    Abstract: The present invention relates to an assay apparatus for detecting a product in a sample. The assay apparatus comprises a fluid pathway with an input of the sample and an input for a reagent with a detectable moiety which transports the sample to a detecting means via a barrier arranged to prevent a product-reagent complex passage but allow passage of unbound reagent and sample. The apparatus also includes supply means for supplying a substance adapted to breakdown the complex into a detectable moiety which can flow through the barrier to the detecting means.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: February 5, 2002
    Assignee: Kalibrant Limited
    Inventors: Derek Adeyemi Palmer, Martin Thomas French
  • Patent number: 6344337
    Abstract: The present invention provides an immunoassay to detect identifying antigens in horses that are infected with Sarcocystis neurona. The immunoassay is preferably an antigen-capture-based assay that relies upon polyclonal or monoclonal antibodies against a 16 (±4) and/or 30 (±4) kDa antigens specific to Sarcocystis neurona to detect the presence of the 16 (±4) and/or 30 (±4) kDa antigens in equine serum or equine cerebrospinal fluid.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: February 5, 2002
    Assignee: Board of Trustees of Michigan State University
    Inventors: Linda S. Mansfield, Mary G. Rossano, Alice J. Murphy, Ruth A. Vrable
  • Patent number: 6344338
    Abstract: The invention relates to an immunochemical method for detecting deposit of Bacillus thuringiensis delta-endotoxin or pesticidally-active fragment thereof on a plant or tree. The invention further relates to kits for using such a method.
    Type: Grant
    Filed: October 6, 1997
    Date of Patent: February 5, 2002
    Assignee: Valent BioSciences Corporation
    Inventors: A. Temple Bowen, Penny L. Hunst, Jennifer K. Swank
  • Patent number: 6344339
    Abstract: Monoclonal antibodies, secreted by hybridoma cell lines, that are directed against an epitope of the extracellular domain of human VEGF-receptor KDR, methods of determining human VEGF-receptor KDR in cell lysates or tissue analysates and the use of the antibodies in analytical assays, in diagnostics and as carrier molecules for therapeutic substances, are described.
    Type: Grant
    Filed: May 19, 1999
    Date of Patent: February 5, 2002
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Menrad, Karl-Heinz Thierauch, Georg Martiny-Baron, Frank Totzke
  • Patent number: 6344340
    Abstract: A method is disclosed for determining the viability of sporocyst-forming protozoa. The method involves treating a sample of protozoa with at least one vital dye and determining the viability of the protozoa in the sample by differential staining. The viability of protozoa in the sample can then be correlated with the viability of protozoa in the population from which the sample was obtained.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: February 5, 2002
    Assignee: Novus International, Inc.
    Inventors: Julia Dibner, Marianne L. Kitchell, Mary Ann Pfannenstiel
  • Patent number: 6344341
    Abstract: This invention relates to recombinant-DNA-technology. Specifically this invention relates to new recombinant yeast cells transformed with SEB1 gene. Yeast cells transformed with several copies of SEB1 gene, or overexpressing the Seb1 protein by some other means, have an increased capacity to produce secreted foreign or endogenous proteins. Further, said new recombinant cells, when transformed with genes expressing suitable hydrolytic enzymes can utilize appropriate macromolecular compounds more efficiently, which results in increased cell mass production and/or more versatile utilization of the compounds in relevant biotechnical applications.
    Type: Grant
    Filed: December 30, 1999
    Date of Patent: February 5, 2002
    Assignee: Valtion teknillinen tetkimuskeskus
    Inventors: Sirkka Keränen, Jaana Toikkanen, Ville Tieaho, Hans Söderlund
  • Patent number: 6344342
    Abstract: HOFNH30 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HOFNH30 polypeptides and polynucleotides in terapy, and diagnostic assays for such.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: February 5, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Ping Tsui, Catherine E. Ellis, Ganesh M. Sathe, Stephanie Van Horn, Robert S. Ames, James J. Foley, Laura R. Fitzgerald, Henry M. Sarau, Jonathan K. Chambers
  • Patent number: 6344343
    Abstract: The present invention relates to a novel product and process for segregating desired product molecules within a cell. Aggregate molecules comprising an adhesive molecule attached to a desired product molecule, are sequestered in or in association with a portion of a lipid bilayer in a protective manner. The invention is additionally directed to methods to use nucleic acid molecules, recombinant cells, delivery vehicles, secretion systems, assays for identifying proteins capable of associating with another protein and biological sensing systems, such embodiments having a variety of therapeutic, diagnostic, biosynthetic production, agricultural, bioremediation and forestry uses.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: February 5, 2002
    Assignee: The Regents of the University of Colorado
    Inventors: Andrew Staehelin, David Galbraith, Thomas Giddings, Christopher Cowan
  • Patent number: 6344344
    Abstract: Uridine-5′-monophosphate is produced by cultivating in a nutrient medium an uridine-5′-monophosphate producing mutant of coryneform bacterium and which is characterized by at least a resistance to growth inhibition by pyrimidine analogue or a deficiency in uridine degrading activity or combination of said property by protoplast fusion. This method has the advantage of decreased production of uracil. Thus, uridine-5′-monophosphate can be produced in much greater yields, compared with known methods.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: February 5, 2002
    Assignee: Ajinomoto Co., Inc.
    Inventors: Lyudmila Anatolievna Kazarinova, Vitaliy Arkadievich Livshits, Ekaterina Sergeevna Preobrazhenskaya, Irina Mikhailovna Starovoytova
  • Patent number: 6344345
    Abstract: Disclosed is a method for producing double-stranded DNA comprising treating double-stranded DNA having a homopolymer part or parts at one or both ends with a restriction enzyme to partly or fully eliminate at least one of the homopolymer part or parts. The restriction enzyme is capable of cleaving double-stranded DNA at a cleavage site separate from a recognition site therefor. Disclosed is a method for determining a nucleotide sequence of double-stranded DNA utilizing one or both strands of the double-stranded DNA as a template, wherein the double-stranded DNA used as the template is double-stranded DNA prepared by the above method of the present invention.
    Type: Grant
    Filed: November 5, 1999
    Date of Patent: February 5, 2002
    Assignee: Riken
    Inventor: Yoshihide Hayashizaki
  • Patent number: 6344346
    Abstract: The invention concerns a polysaccharide with a repeat unit having a lateral chain and comprising six neutral sugars among which glucose and galactose and an acid sugar, a solution greater than 0.2% by weight of said polysaccharide forming a transparent and elastic gel. The invention is applicable in the cosmetic, food, pharmaceutical and oil industries.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: February 5, 2002
    Assignees: Agro Industrie Recherches et Developpement (ARD), Centre National de la Recherche Scientifique (CNRS)
    Inventors: Younes Alami, Thierry Heulin, Michel Milas, Régis De Baynast, Alain Heyraud, Agnès Villain
  • Patent number: 6344347
    Abstract: The present invention provides an industrially efficient method for producing an L-amino acid useful as medicament, chemical agent, food material and feed additive, and the method comprising culturing in a medium a microorganism having an ability to produce the L-amino acid and having resistance to a DNA gyrase inhibitor or a microorganism having an ability to produce the L-amino acid and having both resistance to a DNA gyrase inhibitor and resistance to an aminoquinoline derivative, producing and accumulating the L-amino acid therein and recovering the L-amino acid therefrom.
    Type: Grant
    Filed: September 18, 2000
    Date of Patent: February 5, 2002
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Kuniki Kino, Tetsuya Abe
  • Patent number: 6344348
    Abstract: The invention provides a process for the production of aspartic acid poly-condensate from a carbohydrate comprising the steps of: fermenting a carbohydrate-containing medium by means of a fumaric acid-producing microorganism, whereby a fumarate-containing fermentation liquor is formed; forming a purified ammonium fumarate solution from the fumarate-containing fermentation liquor; enzymatically converting the purified ammonium fumarate into purified ammonium aspartate; heating an aqueous solution of an aspartate salt derived from the purified ammonium aspartate whereby water is removed, an aspartic acid condensate is formed and a second product is formed, which second product is basic and contains the cation of the aspartate salt; and removing and using the basic second product as a reagent in another step of the process.
    Type: Grant
    Filed: November 22, 1999
    Date of Patent: February 5, 2002
    Assignee: Amylum Belgium N.V.
    Inventors: Aharon Eyal, Robert J. Jansen, Asher Vitner, Pierre Cami, Emmanuel Mailly, Thomas Chattaway, Bruno Jarry, Joelle More